SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-020218
Filing Date
2022-05-16
Accepted
2022-05-13 20:18:39
Documents
95
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lhdx-10q_20220331.htm   iXBRL 10-Q 2772973
2 EX-10.2 lhdx-ex102_131.htm EX-10.2 276488
3 EX-31.1 lhdx-ex311_9.htm EX-31.1 20842
4 EX-31.2 lhdx-ex312_10.htm EX-31.2 20813
5 EX-32.1 lhdx-ex321_6.htm EX-32.1 9728
6 EX-32.2 lhdx-ex322_7.htm EX-32.2 8363
  Complete submission text file 0001564590-22-020218.txt   10610778

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA lhdx-20220331.xsd EX-101.SCH 74167
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lhdx-20220331_cal.xml EX-101.CAL 53041
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lhdx-20220331_def.xml EX-101.DEF 232420
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE lhdx-20220331_lab.xml EX-101.LAB 534795
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lhdx-20220331_pre.xml EX-101.PRE 448695
89 EXTRACTED XBRL INSTANCE DOCUMENT lhdx-10q_20220331_htm.xml XML 1773996
Mailing Address 1412 62ND STREET EMERYVILLE CA 94608
Business Address 1412 62ND STREET EMERYVILLE CA 94608 (814) 574-1546
Lucira Health, Inc. (Filer) CIK: 0001652724 (see all company filings)

IRS No.: 272491037 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39976 | Film No.: 22924853
SIC: 2835 In Vitro & In Vivo Diagnostic Substances